Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle.
D000200:Action Potentials / Q000187:drug effects*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology*; D004285:Dogs; D006329:Heart Conduction System / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D010477:Perfusion; D012110:Reserpine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001949:Bretylium Compounds; D012110:Reserpine; D014439:Tyramine